home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

3rd Ubiquitin Research and Drug Discovery • Feb 25-26, 2013 • Las Vegas, Nevada, USA

 
  November 02, 2012  
     
 
GTC, United States
2013/2/25


GTC’s 3rd Ubiquitin Research and Drug Discovery conference, one of three parallel tracks of the 2nd Novel Cancer Therapeutic Summit on February 25 - 26, 2013 in Las Vegas, NV, brings together a balanced mix of experts from industry, academia, biotech and government to collaborate on cutting edge research on the Ubiquitin Pathway, SUMO, Ligases and much more. This year's keynote speaker Aaron Ciechanover won the Nobel Prize for his work in Ubiquitin and two featured speakers Ray Deshaies and Rachel Klevit are recognized leaders in the field of Ubiquitin. With a number of conferences held in cities across the country this conference will be as unique as the city it is held in. Leaders in the field of Ubiquitin, panel discussions and information sharing as well as world class gaming, entertainment and restaurants this conference promises not to disappoint. We look forward to seeing you in Las Vegas!

We look forward to seeing you at the conference!

 
 
 

Conference Date: Feburary 25-26, 2013

Event Link: http://www.gtcbio.com/component/conference/?file=home&cn=3rd+Ubiquitin+Research+and+Drug+Discovery&cid=13

 
 
Organized by: Scott Mccue
Invited Speakers:

 

KEYNOTE SPEAKER (2004 Nobel Laureate in Chemistry)
 
 Aaron Ciechanover
Technion-Israel Institute of Technology
 
FEATURED SPEAKERS
 
Raymond Deshaies 
 Professor, Caltech Investigator
 Howard Hughes Medical Institute
Rachel Klevit
Professor, Biomolecular Structure Center
University of Washington

  

Tsui-Fen Chou 
Assistant Professor
Harbor Medical Center UCLA

 
Yuan Chen
Professor, Molecular Medicine
Beckman Research Institute of City of Hope
 
Lawrence Dick 
Director of Biochemistry
Millennium
 
Judith Frydman
Professor, Biology
Stanford University
 
David Fushman 
Associate Professor, Department of Chemistry and Biochemistry
University of Maryland
 
Anita Gandhi
Principal Scientist, Translational Development
Celgene
 
Alfred Goldberg
Professor, Cell Biology
Harvard Medical School
 
Randy Hampton
Professor, Cell and Developmental Biology
UCSD
 
Mark Hannink
Professor of Biochemistry, Associate Director
Fellowships and Education, Life Sciences Center
University of Missouri
 
Chunhai 'Charlie' Hao 
Associate Professor, Pathology & Laboratory Medicine
Emory University School of Medicine
 
Xavier Jacq
Co-Founder, Head of Biology and Screening
MISSION Therapeutics
 
Jennifer Johnston
Vice President of Research
Elan Pharmaceuticals
 
Gary Kliger
Assistant Professor, Biochemistry
University of Nevada, Las Vegas
 
Ety Klinger
VP R&D
Proteologics
 
Thimo Kurz
Programme Leader in Protein Ubiquitylation, Scottish Institute for Cell Signalling
College of Life Sciences, University of Dundee
 
Zhen-qiang Pan
Professor, Oncological Sciences
Mount Sinai School of Medicine
 
Michael Rape
Associate Professor of Cell and Developmental Biology
University of California at Berkeley
 
Martin Renatus
Research Investigator II
Novartis
 
Ingrid Wertz
Scientist
Genentech
 
Deadline for Abstracts: 2013/2/10
 
Registration: https://www.gtcbio.com/index.php?option=com_register&cn=3rd%20Ubiquitin%20Research%20and%20Drug%20Discovery&cid=13
E-mail: scott.mccue@gtcbio.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.